Cargando…
Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants
BACKGROUND: The absence of an effective treatment and vaccine in HIV-1 pandemic place preventive strategies such as safety and effective microbicide development as a central therapeutic approach to control HIV-1 pandemic nowadays. RESULTS: Studies of cytotoxicity, immune population status, inflammat...
Autores principales: | Rodríguez-Izquierdo, I., Serramía, M. J., Gómez, R., Espinosa, G., Genebat, M., Leal, M., Muñoz-Fernandez, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935742/ https://www.ncbi.nlm.nih.gov/pubmed/35307031 http://dx.doi.org/10.1186/s12951-022-01350-8 |
Ejemplares similares
-
Safety of G2-S16 Polyanionic Carbosilane Dendrimer as Possible HIV-1 Vaginal Microbicide
por: Martin-Moreno, Alba, et al.
Publicado: (2022) -
G2-S16 dendrimer microbicide does not interfere with the vaginal immune system
por: Martín-Moreno, Alba, et al.
Publicado: (2019) -
G1-S4 or G2-S16 carbosilane dendrimer in combination with Platycodin D as a promising vaginal microbicide candidate with contraceptive activity
por: Ceña-Diez, Rafael, et al.
Publicado: (2019) -
Cationic Dendrimer G2-S16 Inhibits Herpes Simplex Type 2 Infection and Protects Mice Vaginal Microbiome
por: Guerrero-Beltrán, Carlos, et al.
Publicado: (2020) -
Baseline and time‐updated factors in preclinical development of anionic dendrimers as successful anti‐HIV‐1 vaginal microbicides
por: Rodríguez‐Izquierdo, Ignacio, et al.
Publicado: (2022)